课题基金 / 基金详情

Efficacy, toxicity, and delivery methods of therapeutic ribonucleic acids (RNAs) for use in human immunodeficeincy virus (HIV) stem cell therapy

Efficacy, toxicity, and delivery methods of therapeutic ribonucleic acids (RNAs) for use in human immunodeficeincy virus (HIV) stem cell therapy
用于人类免疫缺陷病毒 (HIV) 干细胞治疗的治疗性核糖核酸 (RNA) 的功效、毒性和递送方法
批准号：
386550
负责人：
Malard Camille
金额：
$1.27万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-12-01 至 2018-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=386550&lang=en
关键词：
Anti-Hiv Rnas Cell Viability Assays Flow Cytometry Hiv Stem Cell Therapy Hiv/Aids Cure Lentiviral Delivery Systems Molecular Cloning Potency And Toxicity Screens Screens For Immune Activation Western Blots

项目摘要

项目成果

Malard Camille的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
According to the World Health Organization, HIV infects over 36 million individuals. Currently, antiretroviral therapies (ART) are available to control HIV replication and prevent disease progression, but cannot cure the infection. The use of stem cell th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the role of 17beta-estradiol signaling in induced regulatory T cell induction, activity, and stability
海外基金